Net Loss of JHS Svendgaard Laboratories reported to Rs 6.96 crore in the quarter ended March 2025 as against net loss of Rs 0.75 crore during the previous quarter ended March 2024. Sales rose 16.20% to Rs 25.17 crore in the quarter ended March 2025 as against Rs 21.66 crore during the previous quarter ended March 2024.For the full year,net loss reported to Rs 19.74 crore in the year ended March 2025 as against net loss of Rs 4.06 crore during the previous year ended March 2024. Sales rose 29.94% to Rs 92.00 crore in the year ended March 2025 as against Rs 70.80 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales25.1721.66 16 92.0070.80 30 OPM %-21.333.88 --4.36-1.31 - PBDT-4.172.08 PL -1.702.92 PL PBT-6.190.18 PL -9.65-3.43 -181 NP-6.96-0.75 -828 -19.74-4.06 -386 Powered by Capital Market - Live News

JHS Svendgaard Laboratories has revised the meeting of the Board of Directors which was scheduled to be held on 17 May 2025. The meeting will now be held on 27 May 2025.Powered by Capital Market - Live News

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 17 May 2025.Powered by Capital Market - Live News

Net loss of JHS Svendgaard Laboratories reported to Rs 1.84 crore in the quarter ended December 2024 as against net profit of Rs 0.01 crore during the previous quarter ended December 2023. Sales rose 58.46% to Rs 22.66 crore in the quarter ended December 2024 as against Rs 14.30 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales22.6614.30 58 OPM %1.10-0.42 - PBDT0.392.17 -82 PBT-1.580.55 PL NP-1.840.01 PL Powered by Capital Market - Live News

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live News